Andrew McCormack
Founding and General Partner @ Valar Ventures
New York, United States
Andrew McCormack is a Series A investor at Valar Ventures in New York focused on FinTech and Financial Services. Andrew McCormack is based out of New York, New York, and is the founder and managing partner of Valar Ventures. Andrew previously worked at Thiel Capital as a principal. Andrew attended the University of Pennsylvania.
- Total investments:
- 107
- Last investment:
- Lead investor:
- 58%
Last updated:
For AI agents: llms.txt
Industries Andrew McCormack invests in
Stages Andrew McCormack invests in
Countries Andrew McCormack invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- FinTech 27 (25%)
- Financial Services 25 (23%)
- Finance 10 (9%)
- Banking 9 (8%)
- E-Commerce 9 (8%)
Stage
- Series A 28 (26%)
- Series B 21 (20%)
- Seed 17 (16%)
- Series C 12 (11%)
- Series D 8 (7%)
Country
- United States 19 (18%)
- Germany 7 (7%)
- Canada 5 (5%)
- New Zealand 3 (3%)
- Brazil 2 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Octane provides a digital financing platform that enables consumers to obtain personalized loan offers for powersports vehicles, outdoor equipment, and similar lifestyle purchases, using soft credit checks that do not impact credit scores. The platform connects shoppers with dealer partners to support an end-to-end process from online rate checksto in-store financing and loan servicing. Octane also offers tools for dealers to close deals with digital approvals and paperless workflows while accommodating a range of credit profiles. The company’s services include programs tailored for different buyer types and integration features that simplify purchase decisions for both consumers and dealer partners. | $50M / Series F / Dec 15, 2025 | ||
| Panacea is a financial services company created for doctors, by doctors that provides tailored product offerings and service delivery designed specifically for physicians, dentists, and veterinarians throughout their career: from school, through training, and into practice. Panacea’s products cover the full suite of banking needs for this uniquepopulation, including PRN personal loans, student loan refinancing, and practice loans. | $37M / Series B / Jul 14, 2025 | ||
| Syfe is an investment and saving platform empowering people to build their wealth. Syfe offers fully managed portfolios, cash management solutions, and self-directed offerings through its unique neo-brokerage, making it the region’s only all-in-one wealth management platform. Syfe is fully licensed and operational for fund management, financialadvisory, and brokerage in Singapore, Hong Kong & Australia. The company has raised US$ 52.4m to date from prominent backers such as Valar Ventures (Transferwise, N26, Qonto), Unbound Capital (Forto, Cars24), and Partners from DST (Robinhood, Revolut, Brex, Coinbase). | $53M / Series C / Jun 05, 2025 | ||
| Neo Financial is a Canadian financial technology company that directly issues a range of Mastercard credit cards and offers CDIC-insured chequing and savings accounts through partnerships with regulated banks. To help Canadians improve their credit scores, Neo uniquely offers all its cards, including its premium ones, as secured cards. Beyond corebanking, Neo operates a proprietary rewards network of over 11,000 merchant partners, allowing users to earn cashback on everyday spending. | $79M / Series D / Nov 11, 2024 | ||
| Parker is a developer of a digital financial platform designed to help users to pay expenses and manage their e-commerce finances. | $20M / Series B / Nov 09, 2024 | ||
| Syfe is an investment and saving platform empowering people to build their wealth. Syfe offers fully managed portfolios, cash management solutions, and self-directed offerings through its unique neo-brokerage, making it the region’s only all-in-one wealth management platform. Syfe is fully licensed and operational for fund management, financialadvisory, and brokerage in Singapore, Hong Kong & Australia. The company has raised US$ 52.4m to date from prominent backers such as Valar Ventures (Transferwise, N26, Qonto), Unbound Capital (Forto, Cars24), and Partners from DST (Robinhood, Revolut, Brex, Coinbase). | $27M / Series C / Aug 13, 2024 | ||
| Octane provides a digital financing platform that enables consumers to obtain personalized loan offers for powersports vehicles, outdoor equipment, and similar lifestyle purchases, using soft credit checks that do not impact credit scores. The platform connects shoppers with dealer partners to support an end-to-end process from online rate checksto in-store financing and loan servicing. Octane also offers tools for dealers to close deals with digital approvals and paperless workflows while accommodating a range of credit profiles. The company’s services include programs tailored for different buyer types and integration features that simplify purchase decisions for both consumers and dealer partners. | $50M / Series E / Aug 06, 2024 | ||
| Panacea is a financial services company created for doctors, by doctors that provides tailored product offerings and service delivery designed specifically for physicians, dentists, and veterinarians throughout their career: from school, through training, and into practice. Panacea’s products cover the full suite of banking needs for this uniquepopulation, including PRN personal loans, student loan refinancing, and practice loans. | $24.5M / Series B / Jan 16, 2024 | ||
| Petal is a credit card company that is built to help people financially succeed. It aims to make credit honest, simple, and accessible. The company uses machine learning to analyze a customer’s full digital financial record—not just their credit score.Petal has pioneered cash flow underwriting, as an alternative to credit scores, to make creditmore accessible, and offers a simple, modern digital experience that encourages members to build credit, avoid debt, and spend responsibly. Petal is based in New York, New York, and Richmond, Virginia. The Petal credit card is issued by WebBank, Member FDIC. | $35M / Venture - Series Unknown / May 10, 2023 | ||
| Parker is a developer of a digital financial platform designed to help users to pay expenses and manage their e-commerce finances. | $31.1M / Series A / Mar 16, 2023 | ||
| See all 107 investments → | |||
Co-Investors
About Valar Ventures
Valar Ventures is a venture capital firm backed by Peter Thiel. Valar partners with entrepreneurs globally and believes that an increasing number of transformative technology companies will be started outside of Silicon Valley, and that the founders of those companies will benefit from having a partner that understands their unique challenges and opportunities.
Valar Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alison Berger
CFO
|
|||
|
Andrew McCormack
Founding and General Partner
|
|||
Elizabeth Klein
General Counsel
|
|||
|
Erin Ashley Porterfield
Associate
|
|||
James Fitzgerald
Founding Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Andrew McCormack invest in?
Andrew McCormack invests primarily in FinTech, Financial Services and Finance startups, most often at Series A and Series B stage. Most of the 107 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Andrew McCormack?
Public channels for Andrew McCormack include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Andrew McCormack last invest?
The most recent investment recorded for Andrew McCormack closed in Dec 2025. Shizune tracks 107 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
